Newron Pharmaceuticals S.p.A. (LON: 0QOI)
London
· Delayed Price · Currency is GBP · Price in CHF 9.72
+0.85 (9.58%)
Jan 21, 2025, 4:19 PM BST
Newron Pharmaceuticals Market Cap
Newron Pharmaceuticals has a market cap or net worth of 166.07 million as of January 23, 2025. Its market cap has increased by 65.84% in one year.
Market Cap
166.07M
Enterprise Value
197.65M
Revenue
5.91M
Ranking
n/a
PE Ratio
n/a
Stock Price
9.72
Market Cap Chart
Since December 12, 2006, Newron Pharmaceuticals's market cap has increased from 130.73M to 166.07M, an increase of 27.04%. That is a compound annual growth rate of 1.33%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 167.37B |
| GSK plc | 55.25B |
| Haleon | 33.81B |
| Smith & Nephew | 8.96B |
| ConvaTec Group | 4.94B |
| Hikma Pharmaceuticals | 4.62B |
| HUTCHMED (China) | 1.99B |
| Oxford Nanopore Technologies | 1.42B |